Showing results (1-10 of 29) with videos related to
Sort By:
Pageof 3
Medecine Sciences : M/S|January 7, 2020
[Monoclonal antibodies in infectious diseases: new partners in the therapeutic arsenal]Guillaume Desoubeaux, Mireia PelegrinCurrent Opinion in HIV and AIDS|July 31, 2025
Fc-mediated immunological mechanisms in HIV infection: a better understanding for improved therapeutic approachesMar Naranjo-Gomez, Mireia PelegrinCurrent Opinion in HIV and AIDS|May 5, 2023
Vaccinal effect of HIV-1 antibody therapy: dream or reality?Mar Naranjo-Gomez, Mireia PelegrinCurrent Opinion in HIV and AIDS|April 12, 2019
Vaccinal effect of HIV-1 antibody therapyMar Naranjo-Gomez, Mireia PelegrinTrends in Microbiology|October 5, 2015
Antiviral Monoclonal Antibodies: Can They Be More Than Simple Neutralizing Agents?Mireia Pelegrin, Mar Naranjo-Gomez, Marc PiechaczykJournal of Virology|September 29, 2006
Efficient mother-to-child transfer of antiretroviral immunity in the context of preclinical monoclonal antibody-based immunotherapyLaurent Gros, Mireia Pelegrin, Marc Plays, et al.Current Gene Therapy|September 24, 2004
Monoclonal antibody-based genetic immunotherapyMireia Pelegrin, Laurent Gros, Hanna Dreja, et al.JCI Insight|May 4, 2018
Neutrophils are essential for induction of vaccine-like effects by antiviral monoclonal antibody immunotherapiesMar Naranjo-Gomez, Jennifer Lambour, Marc Piechaczyk, et al.Emerging Microbes & Infections|August 18, 2016
Converting monoclonal antibody-based immunotherapies from passive to active: bringing immune complexes into playJennifer Lambour, Mar Naranjo-Gomez, Marc Piechaczyk, et al.Blood|December 25, 2012
Control of regulatory T cells is necessary for vaccine-like effects of antiviral immunotherapy by monoclonal antibodiesRoudaina Nasser, Mireia Pelegrin, Marc Plays, et al.Pageof 3